Profusa (PFSA) Income from Continuing Operations (2022 - 2026)
Profusa (PFSA) posted quarterly Income from Continuing Operations of 4606000.0 for Q1 2026, down 311.28% year-over-year from 2180013.97 in Q1 2025, and up 3.86% quarter-over-quarter from 4791000.0 in Q4 2025.
Profusa (PFSA) Income from Continuing Operations (2022 - 2026) Analysis & Trends
Profusa's Income from Continuing Operations history runs 5 years deep, the most recent figure standing at 4606000.0 for Q1 2026.
- In Q1 2026, Income from Continuing Operations fell 311.28% year-over-year to 4606000.0; the TTM figure through Mar 2026 stood at 40150876.0 (down 345.56% YoY), while the FY2025 annual figure was 70690000.0, down 711.45% from the prior year.
- Income from Continuing Operations for Q1 2026 stood at 4606000.0, up from 4791000.0 in the prior quarter.
- The five-year high for Income from Continuing Operations was 3708996.0 in Q1 2022, with the low at 22557000.0 in Q3 2025.
- The 5-year median for Income from Continuing Operations is 367345.0 (2023), against an average of 2449359.82.
- The sharpest annual moves came in 2024 and 2025: Income from Continuing Operations soared 124.82% in 2024, then sank 24839.79% in 2025.
- Profusa's Income from Continuing Operations stood at 519485.0 in 2022, then slumped by 59.06% to 212692.0 in 2023, then slumped by 3666.2% to 7585032.0 in 2024, then surged by 36.84% to 4791000.0 in 2025, then advanced by 3.86% to 4606000.0 in 2026.
- Business Quant data shows PFSA's Income from Continuing Operations at 4606000.0 in Q1 2026, 4791000.0 in Q4 2025, and 22557000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Profusa | 134,853.87 | -240,146.13 | - | -4.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.61 Mn |
| Dec 31, 2025 | -4.79 Mn |
| Sep 30, 2025 | -22.56 Mn |
| Jun 30, 2025 | -8.20 Mn |
| Mar 31, 2025 | -1.12 Mn |
| Dec 31, 2024 | -7.59 Mn |
| Sep 30, 2024 | 91,177.00 |
| Jun 30, 2024 | -397,487.00 |
| Mar 31, 2024 | -820,277.00 |
| Dec 31, 2023 | 212,692.00 |
| Sep 30, 2023 | -367,345.00 |
| Jun 30, 2023 | 852,389.00 |
| Mar 31, 2023 | 440,895.00 |
| Dec 31, 2022 | 519,485.00 |
| Sep 30, 2022 | 1.76 Mn |
| Jun 30, 2022 | 1.21 Mn |
| Mar 31, 2022 | 3.71 Mn |